2025 Annual Meeting | S2 - Advances in Stroke Imaging and Biomarkers

Date Sunday 04/06/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Location San Diego Convention Center | 10

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Richard Leigh, MD, Faddi G. Saleh Velez, MD

Topic(s) Cerebrovascular Disease and Interventional Neurology

CME Available 2.00 CME credits

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:12 PM PDT	Abstract	001 - Integrated Genomic, Proteomic, and Transcriptomic Profiling Support Cathepsin-B as a Drug Repurposing Target in Cerebral Small Vessel Disease Cyprien Rivier, MD
01:12 PM - 01:24 PM PDT	Abstract	002 - Single-Cell RNA-Seq Analysis Reveals Ferroptosis of Venous Endothelial Cells in Cerebral Amyloid Angiopathy shanshan huang, Sr., MD, PhD
01:36 PM - 01:48 PM PDT	Abstract	003 - Association of Cortical Superficial Siderosis with Poor Functional Outcomes Following Cerebral Amyloid Angiopathy-Related Hemorrhage Alvin Das, MD
01:48 PM - 02:00 PM PDT	Abstract	004 - Pattern of Neuroimaging Markers Related to Cerebral Small Vessel Disease in Carriers of Rare Deleterious Variants Chengqian Li, MD, PhD
02:00 PM - 02:12 PM PDT	Abstract	005 - Application of Hematoma Expansion Biomarkers Based on Proteomics in Predicting Poor Prognosis After Intracerebral Hemorrhage Yuchao Jia, PhD
02:12 PM - 02:24 PM PDT	Abstract	006 - Separation of Stroke from Vestibular Neuritis using the Video Head Impulse Test: Machine Learning Models versus Expert Clinicians Chao Wang
02:24 PM - 02:36 PM PDT	Abstract	007 - Automatic Mild Intracranial Stenosis Detection in the Circle of Willis from Time-of-Flight MRA Chan Nam Nguyen
02:48 PM - 03:00 PM PDT	Abstract	009 - What Can We Learn from Microstructural Properties of Stroke Lesions in Relation to Cognitive Outcomes after Stroke? Andra Braban
03:00 PM - 03:12 PM PDT	Abstract	010 - CTA Collaterals, HIR, and Infarct Volume: Which Imaging Modality Best Predicts Clinical Outcomes in Acute Ischemic Stroke Endovascular Treatment? Mohammed Qussay Ali Al-Sabbagh, MD

Faculty Disclosures
Richard Leigh, MD	The institution of Dr. Leigh has received research support from National Institutes of Health. The institution of Dr. Leigh has received research support from American Heart Association. Dr. Leigh has received intellectual property interests from a discovery or technology relating to health care.
Jose Gutierrez, MD	Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roetzel & Andress, JOHN ASTUNO, JR. L.L.C.. The institution of Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Chan Nam Nguyen	Mr. Nguyen has nothing to disclose.
Julia Huck, PhD	Ms. Huck has received research support from Fonds de. recherche du Québec – Nature et technologie (FRQNT).
Kevin Whittingstall, PhD	Prof. Whittingstall has nothing to disclose.
Cyprien Rivier, MD	Dr. Rivier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyxis Partners.
Shufan Huo, MD, PhD	Dr. Huo has nothing to disclose.
Santiago Clocchiatti-Tuozzo	Mr. Clocchiatti-Tuozzo has nothing to disclose.
Daniela B. Renedo, MD	Dr. Renedo has nothing to disclose.
Richa Sharma, MD	Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care.
Sam Payabvash	Sam Payabvash has nothing to disclose.
Srikant Rangaraju, MBBS	Dr. Rangaraju has nothing to disclose.
Xianjun Dong, PhD	No disclosure on file
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Lauren H. Sansing, MD	Dr. Sansing has nothing to disclose.
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Chunmei Wu, PhD	Dr. Wu has nothing to disclose.
Xiaodong Ye, MD	Dr. Ye has nothing to disclose.
shanshan huang, Sr., MD, PhD	Mrs. huang has nothing to disclose.
SUIQIANG ZHU	No disclosure on file
Andra Braban	Miss Braban has nothing to disclose.
Hollie O'Hanlon, MSc	Miss O'Hanlon has nothing to disclose.
Dragos Gruia, PhD	Mr. Gruia has nothing to disclose.
Pete Hellyer, PhD	Dr. Hellyer has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for H2 Cognitive Designs LTD. Dr. Hellyer has stock in H2 Cognitive Designs LTD.
Joseph Kwan, MD	Dr. Kwan has nothing to disclose.
Soma Banerjee, MD	Prof. banerjee has nothing to disclose.
Adam Hampshire, PhD	Prof. Hampshire has stock in H2CD Ltd. Prof. Hampshire has stock in Future Cognition Ltd.
Fatemeh Geranmayeh, MD	The institution of Dr. Geranmayeh has received research support from Medical Research council .
Chengqian Li, MD, PhD	Dr. Li has nothing to disclose.
Mengyao Wan	Miss Wan has nothing to disclose.
Jingyi Liu, MD	Dr. Liu has nothing to disclose.
Lixin Zhou	Lixin Zhou has nothing to disclose.
Jun Ni	Jun Ni has nothing to disclose.
Fei Han	Fei Han has nothing to disclose.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Ming Yao	Ming Yao has nothing to disclose.
Zi-Yue Liu	Zi-Yue Liu has nothing to disclose.
Yuchao Jia, PhD	Dr. Jia has nothing to disclose.
Mohammed Qussay Ali Al-Sabbagh, MD	Dr. Al-Sabbagh has nothing to disclose.
Sai Kumar Reddy Pasya, MD, MBBS	Dr. Pasya has nothing to disclose.
Tuqa Asedi, MD	Dr. Asedi has nothing to disclose.
Hussein Alsadi	Hussein Alsadi has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD	Dr. Eswaradass has nothing to disclose.
Mahdi Q. Sabbagh	Dr. Sabbagh has nothing to disclose.
Alvin Das, MD	Dr. Das has nothing to disclose.
Avia Abramovitz	Ms. Abramovitz has nothing to disclose.
Elif Gokcal	Elif Gokcal has nothing to disclose.
Ofer Rotschild	Ofer Rotschild has nothing to disclose.
Robert W. Regenhardt, MD, PhD	Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Magdy H. Selim, MD, PhD	Dr. Selim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms Inc..
Anand Viswanathan, MD	Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
Joshua Goldstein	Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. The institution of Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Joshua Goldstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Joshua Goldstein has stock in NControl. Joshua Goldstein has stock in Cayuga. The institution of Joshua Goldstein has received research support from Pfizer. The institution of Joshua Goldstein has received research support from Takeda.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rosand has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for National Football League. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Steven M. Greenberg, MD, PhD, FAAN	Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. The institution of Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Edip M. Gurol, MD	The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer.
Scott E. Kasner, MD, FAAN	Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Diamedica. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from Bristol-Myers Squibb. The institution of Dr. Kasner has received research support from Medtronic. The institution of Dr. Kasner has received research support from WL Gore.
Jens Witsch, MD	Dr. Witsch has a non-compensated relationship as a editorial team member with Neurology Reisdent & Fellow section that is relevant to AAN interests or activities.
Quy X. Cao, PhD	Dr. Cao has nothing to disclose.
Hauke Schneider, MD	The institution of Dr. Schneider has received research support from Medical Faculty, University of Augsburg, Germany.
Kimberly Martinod, PhD	Dr. Martinod has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Peel Therapeutics. The institution of Dr. Martinod has received research support from Peel Therapeutics. Dr. Martinod has received intellectual property interests from a discovery or technology relating to health care.
Christoph J. Maurer, MD	Dr. Maurer has nothing to disclose.
Mathias Stroobants	Mr. Stroobants has nothing to disclose.
Diana Münch	No disclosure on file
Valerie Spalart, MD, PhD	Dr. Spalart has nothing to disclose.
Ansgar Berlis	No disclosure on file
Ulrich P. Jaschinski, MD	Dr. Jaschinski has nothing to disclose.
Markus Naumann, MD	No disclosure on file
Chao Wang	Mr. Wang has received research support from The Garnett Passe and Rodney Williams Memorial Foundation.
Jeevan Sreerama	Mr. Sreerama has received personal compensation for serving as an employee of Soothsayer Analytics. Mr. Sreerama has a non-compensated relationship as a Adjunct Lecturer with University of Sydney that is relevant to AAN interests or activities.
Benjamin Nham, MBBS	Dr. Nham has stock in Resmed. Dr. Nham has stock in CSL.
Nicole Reid, RN	Ms. Reid has nothing to disclose.
Nese Ozalp, Aud	Mrs. Ozalp has nothing to disclose.
James O. Thomas, BMed	Dr. Thomas has received research support from University of New South Wales.
Cecilia Cappelen-Smith, MBBS, PhD, FRACP	Dr. Cappelen-Smith has nothing to disclose.
Zeljka Calic, MD	Dr. Calic has nothing to disclose.
Andrew P. Bradshaw, PhD	Dr. Bradshaw has nothing to disclose.
Sally Rosengren, PhD	Dr. Rosengren has received research support from National Health and Medical Research Council of Australia.
Gulden Akdal, MD	Dr. Akdal has nothing to disclose.
Michael G. Halmagyi, MD	Dr. Halmagyi has nothing to disclose.
Deborah A. Black, PhD	Prof. Black has nothing to disclose.
David Burke, MD, FRACP	Prof. Burke has nothing to disclose.
mukesh prasad, PhD	Dr. prasad has nothing to disclose.
Gnana K. Bharathy, PhD	Dr. Bharathy has received personal compensation for serving as an employee of Australian Research Data Commons. Dr. Bharathy has received personal compensation for serving as an employee of University of Technology Sydney. Dr. Bharathy has a non-compensated relationship as a AI/ ML Specialsit with University of Technology Sydney that is relevant to AAN interests or activities. Dr. Bharathy has a non-compensated relationship as a AI/ML Specialist with Australian Research Data Commons that is relevant to AAN interests or activities.
Miriam S. Welgampola, MD	Dr. Welgampola has nothing to disclose.
Faddi G. Saleh Velez, MD	Dr. Saleh Velez has nothing to disclose.